STAAR Surgical (STAA) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
STAAR Surgical Reports Second Quarter 2016 Results
August 3, 2016 4:01 PM EDTMONROVIA, Calif., Aug. 3, 2016 /PRNewswire/ --Â STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye today reported financial results for the second quarter ended July 1, 2016.
Second Quarter 2016 Overview
Record Quarterly Net Sales of $21.0 Million Up 12% from the Prior Year Quarter Worldwide ICL Sales Up 26% and Units Up 18% from the Prior Year Quarter Worldwide IOL Sales Down 3% and Units Down 15% from the Prior Year Quarter Gross Margin Improved to 69.7% of... More